Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Lynch/Colorectal High Risk Panel GeneDx United States | 10 | 7 |
|
Asper Biogene Asper Biogene LLC Estonia | 135 | 98 |
|
Fulgent Genetics United States | 11 | 1 |
|
Fulgent Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 5 | 1 |
|
Invitae Breast and Gyn Cancers Panel Invitae United States | 33 | 23 |
|
Fulgent Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Fulgent Genetics United States | 1103 | 676 |
|
Intellectual Disability NGS Panel Fulgent Genetics United States | 1058 | 554 |
|
Fulgent Genetics United States | 155 | 69 |
|
Fulgent Genetics United States | 170 | 106 |
|
Colorectal cancer, hereditary nonpolyposis: MSH 6 gene sequence analysis GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases Spain | 3 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.